Knowing more about chloroquine/hydroxycloroquine in COVID-19 patients
- PMID: 33206554
- PMCID: PMC7682553
- DOI: 10.2217/fmb-2020-0247
Knowing more about chloroquine/hydroxycloroquine in COVID-19 patients
Keywords: COVID-19; HCQ dosage; SARS-CoV-2; anti-inflammatory; antiviral; hydroxychloroquine; immunomodulation; observational studies; randomized controlled trials.
References
-
- Gao J, Tian Z, Yang X. Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci. Trends 14(1), 72 (2020). - PubMed
-
- Savarino A, Lucia MB, Rastrelli E. et al. Anti-HIV effects of chloroquine: inhibition of viral particle glycosylation and synergism with protease inhibitors. J. Acquir. Immune. Defic. Syndr. 35(3), 223 (2004). - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous